S-nitrosohemoglobin: a dynamic activity of blood involved in vascular control
《Nature》
Polynitrosylated proteins: characterization, bioactivity and functional consequences
《Proc. Natl. Acad. Sci. U.S.A.》
1997年
Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient
《Science》
1998年
The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats
《Eur. J. Pharmacol.》
1999年
Dual actions of S-nitrosylated derivative of vasoactive intestinal peptide as a vasoactive intestinal peptide-like mediator and a nitric oxide carrier
Physicochemistry, pharmacokinetics and pharmacodynamics of S-nitrosocaptopril crystals, a new nitric oxide donor
《J. Pharm. Sci.》
2001年
In vitro and in vivo assessment of cellular permeability and pharmacodynamics of S-nitrosylated captopril, a nitric oxide donor
《Br.J. Pharmacol.》
2002年
Effect of nanonization on absorption of 301029: Ex vivo and in vivo pharmacokinetic correlations determined by LC/MS
《Pharm. Res.》
2003年
Carbendazim: Disposition, cellular permeability, metabolite identification and pharmacokinetic comparison with its nanoparticle
《J. Pharm. Sci.》
Effect of Nitric Oxide on Cytotoxicity of Taxol: enhanced Taxol transcellular permeability
《Biochem. Pharmacol.》
2005年
Pharmacodynamic and pharmacokinetic characteristics of SQ109, a new diamine-based antitubercular drug
《Br.J. Pharmacol.》
Pharmacoproteomic effects of isoniazid, ethambutol,SQ109 on Mycobacterium tuberculosis H37Rv
《J.Pharmacol. Exp. Ther.》
2006年
Interspecies pharmacokinetics and in vitro metabolism of SQ109
《Br.J. Pharmacol》
2007年
The conduct of drug metabolism studies considered good practice (II): in vitro experiments
《Curr. Drug Metab.》
2008年
Bcl-2 antagonist ApoGossypol (NSC736630) displays single-agent activity in Bcl-2 transgenic mice and has superior efficacy with less toxicity compared to Gossypol (NSC19048)
《Blood》
2009年
Current Evaluation of Ginseng (I): Etymology, Pharmacognosy, Phytochemistry, Market and Regulations
《Curr. Med. Chem.》
Current Evaluation of the Millennium Phytomedicine― Ginseng (II): Collected Chemical Entities, Modern Pharmacology, and Clinical Applications Emanated from Traditional Chinese Medicine
2010年
Metallofullerene Nanoparticles Overcome Tumor Resistance to Cisplatin by Reactivating Endocytosis
《Proc. Natl. Acad. Sci. U.S.A.》
2011年
Fast Evolving Nanotechnology and Relevant Programs and Entities in China
《Nano Today》
2011年
Compilation of 222 Drugs’ Plasma Protein BindingData and Guidance for Study Designs
賈力在美國阿拉巴馬大學為研究生講授“現代藥物設計與開發（Modern Drug Design and Development）”、“新藥研發套用的基本知識：過程、數據集成和包裝準備（Basic Knowledge about Investigational New Drug Application: Processes, Data Integration and Package Preparations）”、“新藥研發的跨學科知識和技能（Interdisciplinary knowledge and skills on new drug research and development）”、“藥代動力學（Pharmacokinetics）”等課程。
